Rabies Immune Globulin (Human) (Bayrab, Hyperrab)
Rabies Immune Globulin (Human) is an FDA-licensed reference biologic from Grifols Therapeutics LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1974
Reference approved
Reference product
Bayrab, Hyperrab Rabies Immune Globulin (Human)
Grifols Therapeutics LLC
- Approved
- Jun 12, 1974
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Rabies Immune Globulin (Human), in chronological order.
Reference approval
Approval date of the reference Rabies Immune Globulin (Human) product.
52 yr 9 mo ago
Frequently asked questions
Are there biosimilars approved for Rabies Immune Globulin (Human) (Bayrab, Hyperrab)?
No 351(k) biosimilars or interchangeable biosimilars referencing Rabies Immune Globulin (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.